Aflac Incorporated: Mizuho raises target price to $112 from $107
AFL•Mizuho raised its target price for Aflac Incorporated to $112 from $107.
Related News
Cullinan's Velinotamig reduces disease activity in 8 of 9 evaluable patients in early lupus study
CGEM•
Cognition Therapeutics to attend Jefferies Global Healthcare Conference
CGTX•
GlobalFoundries: Argus Research cuts target price to $70 from $90
GFS•
AIoT SaaS provider Powerfleet's Q2 revenue slightly beats estimates
AIOT•
Trex Company, Inc.: Stifel raises target price to $62 from $55
TREX•